Brief: Genxone Offer For DNA Sequencing Project Chosen As Most Favourable By Medical University Of Warsaw
14/04/2026 06:10
April 14 (Reuters) - Genxone S.A. GX1.WA: SAID ON MONDAY THAT ITS 93,990 ZLOTY OFFER FOR DNA SEQUENCING SERVICES HAD BEEN CHOSEN AS MOST FAVOURABLE IN TENDER BY WARSAW MEDICAL UNIVERSITY RESEARCH SERVICE IS RELATED TO GUT MICROBIOTA SEQUENCING PROJECT Source text: nEM2qPJjYa Further company coverage: GX1.WA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Genxone SA
See all newsBrief: Genxone Q2 Net Loss 0.3 Million Zlotys
Brief: Genxone 1.2 Mln Zloty Offer For NGS Sequencing Services Chosen As Most Favourable In Tender
Brief: Genxone Signs 93,990 Zloty Contract With Medical University Of Warsaw For Gut Microbiota DNA Sequencing Services
Brief: Genxone Q1 Net Loss 0.5 Million Zlotys
Brief: Genxone FY Net Loss 2.6 Million Zlotys